US: 35 Companies Sign On For Producing Generic Versions of Covid-19 Pill of Pfizer
Thirty five companies across the world have now signed the agreements for the purpose of producing the generic versions of the covid-19 pills developed by Pfizer and also selling them inexpensively in around 95 low income countries that together have been home for around half of the population of the world. The Medicines Patent Tool, […]
Continue Reading